Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Yongren Medical Innovation is a Chinese medical technology company specializing in the development and commercialization of advanced ventricular assist devices (VADs), commonly known as artificial hearts. As a strategic expansion of the Yongrenxin group, the company focuses on providing long-term mechanical circulatory support for patients suffering from end-stage heart failure. Their core technology, the EVAHEART system, is a rotary blood pump designed to mimic physiological pulsatility, which helps reduce complications associated with traditional continuous-flow pumps. The company operates a significant manufacturing and R&D base in Changsha, Hunan, aimed at localizing high-end cardiovascular solutions. By integrating Japanese-originated technology with domestic innovation, Hunan Yongren plays a vital role in the Chinese artificial heart market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Yongren Medical Innovation.